These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
357 related articles for article (PubMed ID: 33036939)
21. CLINICAL PRACTICE GUIDELINES FOR THE PERIOPERATIVE NUTRITION, METABOLIC, AND NONSURGICAL SUPPORT OF PATIENTS UNDERGOING BARIATRIC PROCEDURES - 2019 UPDATE: COSPONSORED BY AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS/AMERICAN COLLEGE OF ENDOCRINOLOGY, THE OBESITY SOCIETY, AMERICAN SOCIETY FOR METABOLIC & BARIATRIC SURGERY, OBESITY MEDICINE ASSOCIATION, AND AMERICAN SOCIETY OF ANESTHESIOLOGISTS - Mechanick JI; Apovian C; Brethauer S; Garvey WT; Joffe AM; Kim J; Kushner RF; Lindquist R; Pessah-Pollack R; Seger J; Urman RD; Adams S; Cleek JB; Correa R; Figaro MK; Flanders K; Grams J; Hurley DL; Kothari S; Seger MV; Still CD Endocr Pract; 2019 Dec; 25(12):1346-1359. PubMed ID: 31682518 [No Abstract] [Full Text] [Related]
22. Mechanisms of Action of Surgical Interventions on Weight-Related Diseases: the Potential Role of Bile Acids. Mazidi M; de Caravatto PP; Speakman JR; Cohen RV Obes Surg; 2017 Mar; 27(3):826-836. PubMed ID: 28091894 [TBL] [Abstract][Full Text] [Related]
23. Acute Changes of Bile Acids and FGF19 After Sleeve Gastrectomy and Roux-en-Y Gastric Bypass. Chen Y; Lu J; Nemati R; Plank LD; Murphy R Obes Surg; 2019 Nov; 29(11):3605-3621. PubMed ID: 31273649 [TBL] [Abstract][Full Text] [Related]
25. Role of Bile Acids and GLP-1 in Mediating the Metabolic Improvements of Bariatric Surgery. Albaugh VL; Banan B; Antoun J; Xiong Y; Guo Y; Ping J; Alikhan M; Clements BA; Abumrad NN; Flynn CR Gastroenterology; 2019 Mar; 156(4):1041-1051.e4. PubMed ID: 30445014 [TBL] [Abstract][Full Text] [Related]
26. Metabolic surgery: action via hormonal milieu changes, changes in bile acids or gut microbiota? A summary of the literature. Sweeney TE; Morton JM Best Pract Res Clin Gastroenterol; 2014 Aug; 28(4):727-40. PubMed ID: 25194186 [TBL] [Abstract][Full Text] [Related]
27. Ménage-à-trois of bariatric surgery, bile acids and the gut microbiome. Raghow R World J Diabetes; 2015 Apr; 6(3):367-70. PubMed ID: 25897347 [TBL] [Abstract][Full Text] [Related]
28. Role of Bile Acids in the Regulation of Food Intake, and Their Dysregulation in Metabolic Disease. Xie C; Huang W; Young RL; Jones KL; Horowitz M; Rayner CK; Wu T Nutrients; 2021 Mar; 13(4):. PubMed ID: 33800566 [TBL] [Abstract][Full Text] [Related]
29. FXR is a molecular target for the effects of vertical sleeve gastrectomy. Ryan KK; Tremaroli V; Clemmensen C; Kovatcheva-Datchary P; Myronovych A; Karns R; Wilson-Pérez HE; Sandoval DA; Kohli R; Bäckhed F; Seeley RJ Nature; 2014 May; 509(7499):183-8. PubMed ID: 24670636 [TBL] [Abstract][Full Text] [Related]
30. The Gut Microbiota as a Mediator of Metabolic Benefits after Bariatric Surgery. Anhê FF; Varin TV; Schertzer JD; Marette A Can J Diabetes; 2017 Aug; 41(4):439-447. PubMed ID: 28552651 [TBL] [Abstract][Full Text] [Related]
31. Gut Microbial Predictors of Type 2 Diabetes Remission Following Bariatric Surgery. Davies N; O'Sullivan JM; Plank LD; Murphy R Obes Surg; 2020 Sep; 30(9):3536-3548. PubMed ID: 32447634 [TBL] [Abstract][Full Text] [Related]
32. The role of bile acids in reducing the metabolic complications of obesity after bariatric surgery: a systematic review. Penney NC; Kinross J; Newton RC; Purkayastha S Int J Obes (Lond); 2015 Nov; 39(11):1565-74. PubMed ID: 26081915 [TBL] [Abstract][Full Text] [Related]
33. Mechanisms underlying the weight loss effects of RYGB and SG: similar, yet different. Pucci A; Batterham RL J Endocrinol Invest; 2019 Feb; 42(2):117-128. PubMed ID: 29730732 [TBL] [Abstract][Full Text] [Related]
34. Bariatric surgery and type 2 diabetes: are there weight loss-independent therapeutic effects of upper gastrointestinal bypass? Chondronikola M; Harris LL; Klein S J Intern Med; 2016 Nov; 280(5):476-486. PubMed ID: 27739136 [TBL] [Abstract][Full Text] [Related]
35. Bariatric/Metabolic Surgery Induces Noticeable Changes of Microbiota and Their Secreting Extracellular Vesicle Composition in the Gut. Huh YJ; Seo JY; Nam J; Yang J; McDowell A; Kim YK; Lee JH Obes Surg; 2019 Aug; 29(8):2470-2484. PubMed ID: 31129882 [TBL] [Abstract][Full Text] [Related]
36. Updates in weight loss surgery and gastrointestinal peptides. Svane MS; Bojsen-Møller KN; Madsbad S; Holst JJ Curr Opin Endocrinol Diabetes Obes; 2015 Feb; 22(1):21-8. PubMed ID: 25517025 [TBL] [Abstract][Full Text] [Related]
37. Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: understanding weight loss and improvements in type 2 diabetes after bariatric surgery. Scott WR; Batterham RL Am J Physiol Regul Integr Comp Physiol; 2011 Jul; 301(1):R15-27. PubMed ID: 21474429 [TBL] [Abstract][Full Text] [Related]
38. Increased Bile Acids and FGF19 After Sleeve Gastrectomy and Roux-en-Y Gastric Bypass Correlate with Improvement in Type 2 Diabetes in a Randomized Trial. Nemati R; Lu J; Dokpuang D; Booth M; Plank LD; Murphy R Obes Surg; 2018 Sep; 28(9):2672-2686. PubMed ID: 29987678 [TBL] [Abstract][Full Text] [Related]
39. Metabolic effects of bariatric surgery in patients with moderate obesity and type 2 diabetes: analysis of a randomized control trial comparing surgery with intensive medical treatment. Kashyap SR; Bhatt DL; Wolski K; Watanabe RM; Abdul-Ghani M; Abood B; Pothier CE; Brethauer S; Nissen S; Gupta M; Kirwan JP; Schauer PR Diabetes Care; 2013 Aug; 36(8):2175-82. PubMed ID: 23439632 [TBL] [Abstract][Full Text] [Related]
40. The role of bariatric surgery to treat diabetes: current challenges and perspectives. Koliaki C; Liatis S; le Roux CW; Kokkinos A BMC Endocr Disord; 2017 Aug; 17(1):50. PubMed ID: 28797248 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]